Close Menu


Additional funding opportunities

Research Funding Opportunities

Tools to Find Funding

Grants Awarded for Health Sciences Research

Title Type $ Amount Activity Investigator Unit Sponsor Date
A Phase 3, Randomized, Double-blind, Controlled Study Evaluating the Efficacy and Safety of VX-121 Combination Therapy in Subjects With Cystic Fibrosis Who Are Heterozygous for F508del and a Minimal F Contract $587,778.40 Clinical Trial Cori Daines Asthma/Airway Disease Rsch Ctr Vertex Pharmaceuticals, Incorporated 03/2022
A Phase 1b, Randomized, Blinded, Dose-Determined Study Evaluating the Safety and Tolerability Profile of Intervention with AT-100 (rhSP-D) in Preterm Neonates at High Risk for the Development of Bronc Contract $111,966.00 Clinical Trial Ranjit Kylathu Pediatrics Airway Therapeutics, Inc. 03/2022
A Phase 1-2, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of ADP101 for Oral Immunotherapy in Food-Allergic Children and Adults (The Harmony Study) Contract $12,285.00 Clinical Trial Heather Cassell Asthma/Airway Disease Rsch Ctr Alladapt Immunotherapeutics, Inc. 03/2022
REU Site: The National Summer Undergraduate Research Project Grant $935,426.00 Research Training Michael Johnson Immunobiology National Science Foundation 02/2022
Neurological effects of toxic metal exposure in model rodents collected in zones of industrial agriculture on the U.S.-Mexico border Fellowship $140,701.00 Research Training Jonathan Credo Community Environment & Policy National Institutes of Health 02/2022
Defining the role of PIM kinases in hypoxia-induced prostate cancer invasion Fellowship $92,072.00 Research Training Corbin Jensen Cellular & Molecular Medicine National Cancer Institute 02/2022
Thrombocyte Regulation of Anti-Parasite Immunity Grant $767,500.00 Research Alfred Bothwell Immunobiology National Institute of Allergy and Infectious Disease 02/2022
The Role of the P450 Eicosanoids in the Development of Hydrocephalus Grant $50,000.00 Research Justin Cetas Neurosurgery Hydrocephalus Association 02/2022
Targeting Lysosomal Vulnerabilities in Renal Pathogenesis Grant $2,404,165.00 Research Steffan Nawrocki Medicine National Cancer Institute 02/2022
PhytoSERM Efficacy to Prevent Menopause Associated Decline in Brain Metabolism and Cognition: A Double-Blind, Randomized, Placebo-Controlled Phase 2 Clinical Trial Grant $7,674,939.00 Research Roberta Brinton UAHS Brain Science National Institutes of Health 02/2022
Journey to Mars: Pharmaceutics for deep-space explorations Grant $10,000.00 Research Jerome Lacombe COM Phx NanoBioscience & Med French American Cultural Exchange 02/2022
Independent Hemocompatibility Assessment of ABIOMED Mechanical Circulatory Support Devices: Hemolysis and Platelet Activation Studies Contract $600,000.00 Research Marvin Slepian UAHS Research ABIOMED, Inc. 02/2022
Impact of Occult Autoimmune ILD on outcomes in IPF Contract $29,000.00 Research Marilyn Glassberg Csete COM Phx Internal Medicine Genentech, Incorporated 02/2022
Focal Adhesion Kinase - Tumor Biology and Therapeutics Grant $1,626,634.00 Research Timothy Marlowe COM Phx Internal Medicine National Cancer Institute 02/2022
A Randomized Phase II Trial of the Altering Intake, Managing Symptoms (AIMS) Intervention for Bowel Dysfunction in Rectal Cancer Survivors Grant $93,773.00 Research Cynthia Thomson Health Promotion Sciences Beckman Research Institute of The City of Hope 02/2022
ATHN 10: Leveraging the ATHNdataset to Document the State of Rare Coagulation Disorders in the United States Contract $900.00 Other Sponsored Activity Ravitharan Krishnadasan Medicine American Thrombosis and Hemostasis Network 02/2022
Serum Protein-Based Indices for the Progression of Fracture Healing and Nonunion Contract $42,700.00 Clinical Trial Jason Lowe Orthopedic Surgery Johns Hopkins University 02/2022
Reference Range and Clinical Performance Evaluation of Elecsys IL-6 Assay in Neonatal Sepsis (US); Collection Study. Contract $16,584.52 Clinical Trial Ranjit Kylathu Pediatrics Icon Clinical Research, Incorporated 02/2022
Randomized, Double-Blinded, Placebo-Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of a Multi- Dose Regimen of Oral Varespladib-Methyl in Subjects Bitten by Venomous Snakes (BRAVO Contract $621,067.52 Clinical Trial Jarrod Mosier Dept of Emergency Medicine Ophirex 02/2022
Prospective Clinical Trial to Detect Liver Cancer through Quantification of cfDNA Methylation in Blood Samples (CLiMB) Contract $381,978.48 Clinical Trial Geoffrey Block Liver Research Institute Helio Health 02/2022
Pragmatic, Randomized, Blinded Trial to Shorten Pharmacologic Treatment of Newborns with Neonatal Opioid Withdrawal Syndrome (NOWS) Contract $285,720.00 Clinical Trial Ranjit Kylathu Pediatrics RTI International 02/2022
Percutaneous Deep Vein Arterialization for the Treatment of Late-Stage Chronic Limb-Threatening Ischemia (The PROMISE II Trial) Contract $251,024.00 Clinical Trial Wei Zhou Surgery LimFlow, Inc. 02/2022
INNATE: Immunotherapy During Neoadjuvant Therapy for Rectal Cancer, a Phase II Randomized Multi-center Trial With and Without APX005M, an Anti-CD40 Agonist Contract $70,892.00 Clinical Trial Aaron Scott Cancer Center Division University of Texas Southwestern Medical Center 02/2022
Assessment of the CARILLON Mitral Contour System in Treating Functional Mitral Regurgitation Associated with Heart Failure Contract $274,041.75 Clinical Trial Kwan Lee Sarver Heart Center Cardiac Dimensions, Inc. 02/2022